Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-platelet antibody and platelet function].

Y Kurata1, Y Tomiyama

  • 1Department of Blood Transfusion, Osaka University Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of clinical utility of contrast-enhanced MRI in the diagnosis of ectopic pregnancy.

Clinical radiology·2020
Same author

A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.

Journal of thrombosis and haemostasis : JTH·2018
Same author

A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.

Vox sanguinis·2014
Same author

Compact 100Gb/s DP-QPSK integrated receiver module employing three-dimensional assembly technology.

Optics express·2014
Same author

Chronic cadmium treatment induces tubular nephropathy and osteomalacic osteopenia in ovariectomized cynomolgus monkeys.

Veterinary pathology·2013
Same author

Central PACAP mediates the sympathetic effects of leptin in a tissue-specific manner.

Neuroscience·2013
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

This study investigated anti-platelet antibodies targeting glycoprotein IIb/IIIa. One antibody, OP-G2, induced platelet aggregation by binding near the fibrinogen site, unlike others that inhibited it.

Area of Science:

  • Immunology
  • Hematology
  • Biochemistry

Context:

  • Platelet aggregation is crucial for hemostasis and thrombosis.
  • Anti-platelet antibodies can modulate platelet function, impacting various clinical conditions.
  • Glycoprotein IIb/IIIa (GPIIb/IIIa) is a key receptor involved in platelet aggregation, binding fibrinogen.

Purpose:

  • To analyze the effects of various anti-platelet antibodies on platelet function.
  • To characterize the binding epitope of a specific murine monoclonal antibody, OP-G2, targeting GPIIb/IIIa.
  • To compare the binding characteristics of OP-G2 with other anti-GPIIb/IIIa antibodies.

Summary:

  • Investigated the impact of murine monoclonal antibodies, autoantibodies, and alloantibodies on platelet function.

Related Experiment Videos

  • Identified GPIIb/IIIa as the target antigen for these antibodies, crucial for fibrinogen receptor activity.
  • Observed that while some antibodies inhibited aggregation, OP-G2 induced it, requiring divalent cations and fibrinogen, suggesting binding near the fibrinogen site.

    • Impact:

    • Provides insights into the complex interactions between anti-platelet antibodies and GPIIb/IIIa.
    • Highlights the potential of specific antibodies like OP-G2 to modulate platelet aggregation.
    • Contributes to understanding antibody-mediated effects on platelet function, relevant for thrombotic disorders and immune therapies.